Role of echocardiography in patients undergoing elective cardioversion of atrial fibrillation

Circulation

Volumn 98, Issue 5, 1998, Pages 479-486

  Silverman, David I ^a   Manning, Warren J ^b,c,d  

^a UConn Health John Dempsy Hospital   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Anticoagulants; Atrial flutter; Cardioversion; Echocardiography; Fibrillation

Indexed keywords

HEPARIN; WARFARIN;

ANTICOAGULATION; CARDIOVERSION; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SURGICAL ANATOMY; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 0032483125     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.5.479     Document Type: Review

References (67)

1. Heart and Stroke Facts. Statistical Supplement. Dallas, Tex: American Heart Association; 1996:14.
2. Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation: the Framingham Heart Study. Circulation. 1994;89:724-730.
3. Pritchett E. Management of atrial fibrillation. N Engl J Med. 1992;326: 1264-1271.
4. Sohara H, Amitani S, Kurose M, Miyahara K. Atrial fibrillation activates platelets and coagulation in a time-dependent manner: a study in patients with paroxysmal atrial fibrillation. J Am Coll Cardiol. 1997;29:106-112.
5. The Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation, II: echocardiograph, features of patients at risk. Ann Intern Med. 1992;116:6-12.
6. Aschenberg W, Schlüter M, Kremer P, Schroder E, Siglow V, Bleifeld W. Transesophageal two-dimensional echocardiography for the detection of left atrial appendage thrombus. J Am Coll Cardiol. 1986;7:163-166.
7. Yabek SM, Isabel-Jones J, Bhatt DR, Nakazawa M, Marks RA, Jarmakani JM. Echocardiographic determination of left atrial volumes in children with congenital heart disease. Circulation. 1976;53:268-272.
8. Pedersen P, Kastrup J, Brinch K, Godtfredsen J, Boysen G. Relation between left atrial dimension and duration of atrial fibrillation. Am J Cardiol. 1987;60:382-384.
9. Sanfillippo AJ, Abascal VM, Sheehan M, Oertel LB, Harrigan P, Hughes RA, Weyman AE. Atrial enlargement as a consequence of atrial fibrillation: a prospective echocardiographic study. Circulation. 1990;82: 792-797.
10. Manning WJ, Leeman DE, Gotch PJ, Come PC. Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation. J Am Coll Cardiol. 1989;13:617-623.
11. Aronow WS, Ahn C, Kronzon I. Echocardiographic findings associated with atrial fibrillation in 1,699 patients aged >60 years. Am J Cardiol. 1995;76:1191-1192.
12. Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation: the Framingham Heart Study. Circulation. 1994;89:724-730.
13. Petersen P, Kastrup J, Brinch K, Godtfredsen J, Boysen G. Relation between left atrial dimension and duration of atrial fibrillation. Am J Cardiol. 1987;60:382-384.
14. Suarez GS, Lampert S, Ravid S, Lown B. Changes in left atrial size in patients with lone atrial fibrillation. Clin Cardiol. 1991;14:652-656.
15. DeMaria AN, Lies JE, King JF, Miller RR, Amsterdam EA, Mason DT. Echographic assessment of atrial transport, mitral movement and ventricular performance following electroversion of supraventricular arrhythmias. Circulation. 1975;51:273-282.
16. Gosselink ATM, Crijns HJGM, Hamer HPM, Hillege H, Lie KI. Changes in left and right atrial size after cardioversion of atrial fibrillation: role of mitral valve disease. J Am Coll Cardiol. 1993;22:1666-1672.
17. Van Gelder IC, Crijns HJ, Van Gilst WH, Hamer HP, Lie KI. Decrease of right and left atrial sizes after direct current electrical cardioversion in chronic atrial fibrillation. Am J Cardiol. 1991;67:93-95.
18. Hoglund C, Rosenhamer G. Echocardiographic left atrial dimension as a predictor of maintaining sinus rhythm after conversion of atrial fibrillation. Acta Med Scand. 1985;217:411-415.
19. Dittrich HC, Erickson JS, Schneiderman T, Blacky AR, Savides T, Nicod PH. Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation. Am J Cardiol. 1989;63:193-197.
20. Volgman AS, Iftikhar F, Soble JS, Vallesteros A, Neumann A, Liebson PR, Mukhtar KN. Effect of left atrial size on recurrence of atrial fibrillation after electrical cardioversion: atrial dimension versus volume. Am J Card Imaging. 1996;10:261-265.
21. Arnar DO, Danielsen R. Factors predicting maintenance of sinus rhythm after direct current cardioversion of atrial fibrillation and flutter: a reanalysis with recently acquired data. Cardiology. 1996;87:181-188.
22. Brodsky MA, Allen BJ, Capparelli EV, Luckett CR, Morton R, Henry WL. Factors determining maintenance of sinus rhythm after chronic atrial fibrillation with left atrial dilatation. Am J Cardiol. 1989;63:1065-1068.
23. Morris JJ, Kong Y, North WC, McIntosh HD. Experience with 'cardioversion' of atrial fibrillation and flutter. Am J Cardiol. 1964;14:94-100.
24. Bjerkelund C, Orning OM. The efficacy of anticoagulant therapy in preventing embolism related to D. C. electrical conversion of atrial fibrillation. Am J Cardiol. 1969;23:208-216.
25. Weinberg DM, Mancini GBJ. Anticoagulation for cardioversion of atrial fibrillation. Am J Cardiol. 1989;63:745-746.
26. Arnold AZ, Mick MJ, Mazurek RP, Loop FD, Trohman RG. Role of prophylactic anticoagulation for direct cardioversion in patients with atrial fibrillation or atrial flutter. J Am Coll Cardiol. 1992;19:851-855.
27. Roy D, Marchand E, Gagné P, Chabot M, Cartier R. Usefulness of anticoagulant therapy in the prevention of embolic complications of atrial fibrillation. Am Heart J. 1986;112:1039-1043.
28. Klein AL, Grimm RA, Black IW, Leung DY, Chung MK, Vaughn SE, Murray D, Miller DP, Arheart KL, for the ACUTE Investigators. Cardioversion guided by transesophageal echocardiography: the ACUTE pilot study: a randomized, controlled trial. Ann Intern Med. 1997;126: 200-209.
29. Rokseth R, Storstein O. Quinidine therapy of chronic auricular fibrillation: the occurrence and mechanism of syncope. Arch Intern Med. 1963;111:184-189.
30. Schlicht JR, Davis RC, Naqi K, Cooper W, Rao BV. Physician practices regarding anticoagulation and cardioversion of atrial fibrillation. Arch Intern Med. 1996;156:290-294.
31. Carlsson J, Tebbe U, Rox J, Harmjanz D, Haerten K, Neuhaus KL, Seidel F, Niederer W, Miketic S, for the ALKK-Study Group. Cardioversion of atrial fibrillation in the elderly. Am J Cardiol. 1996;78:1380-1384.
32. Manning WJ, Silverman DI, Gordon SPF, Krumholz HM, Douglas PS. Cardioversion from atrial fibrillation without prolonged anticoagulation with the use of transesophageal echocardiography to exclude the presence of atrial thrombi. N Engl J Med. 1993;328:750-755.
33. Stoddard MF, Dawkins P, Prince CR, Longaker RA. Transesophageal echocardiographic guidance of cardioversion in patients with atrial fibrillation. Am Heart J. 1995;129:1204-1215.
34. Daniel WG, Erbel R, Kasper W, Visser CA, Engberding R, Sutherland GR, Grube E, Hanrath P, Maisch B, Dennig K, Schartl M, Kremer P, Angermann C, Iliceto S, Curtius JM, Mügge A. Safety of transesophageal echocardiography: a multicenler survey of 10,419 examinations. Circulation. 1991;83:817-821.
35. Khandheria BK, Seward JB, Tajik AJ. Transesophageal echocardiography. Mayo Clin Proc. 1994;69:856-863.
36. Mügge A, Daniel WG, Hausmann D, Godke J, Wagenbreth I, Lichtlen PR. Diagnosis of left atrial appendage thrombi by transesophageal echocardiography: clinical implications and follow-up. Am J Card Imaging. 1990;4:173-179.
37. Olson JD, Goldenberg IF, Federsen W, Brandt D, Kane M, Daniel JA, Nelson RR, Mooney MR, Lange HW. Exclusion of atrial thrombus by transesophageal echocardiography. J Am Soc Echocardiogr. 1992;5: 52-56.
38. Hwang JJ, Chen JJ, Lin SC, Tseng YZ, Kuan P, Lien WP, Lin FY, Chu SH, Hung CR, How SW. Diagnostic accuracy of transesophageal echocardiography for detecting left atrial thrombi in patients with rheumatic heart disease having undergone mitral valve operations. Am J Cardiol. 1993;72:677-681.
39. Manning WJ, Weintraub RM, Waksmonski CA, Haering JM, Rooney PS, Maslow AD, Johnson RG, Douglas PS. Accuracy of transesophageal echocardiography for identifying left atrial thrombi: a prospective, intraoperative study. Ann Intern Med. 1995;123:817-822.
40. Fatkin D, Scalia G, Jacobs N, Burstow D, Leung D, Walsh W, Feneley M. Accuracy of biplane transesophageal echocardiography in detecting left atrial thrombus. Am J Cardiol. 1996;77:321-323.
41. Manning WJ, Silverman DI, Keighley CS, Oettgen P, Douglas PS. Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short term anticoagulation: final results of a prospective 4.5-year study. J Am Coll Cardiol. 1995;25:1354-1361.
42. Dittrich HC, Erickson JS, Schneiderman T, Blacky AR, Savides T, Nicod PH. Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation. Am J Cardiol. 1989;63:193-197.
43. Flaker GC, Fletcher KA, Rothbart RM, Halperin JL, Hart RG. Clinical and echocardiographic features of intermittent atrial fibrillation that predict recurrent atrial fibrillation. Am J Cardiol. 1995;76:355-358.
44. Manning WJ, Silverman DI, Katz SE, Riley MF, Come PC, Doherty RM, Munson JT, Douglas PS. Impaired left atrial mechanical function after cardioversion: relationship to the duration of atrial fibrillation. J Am Coll Cardiol. 1994;23:1535-1540.
45. Grimm RA, Leung DY, Black IW, Stewan WJ, Thomas JD, Klein AL. Left atrial appendage "stunning" after spontaneous conversion of atrial fibrillation demonstrated by transesophageal Doppler echocardiography. Am Heart J. 1995;130:174-176.
46. Manning WJ, Silverman DI, Katz SE, Riley MF, Doherty RM, Munson JT, Douglas PS. Temporal dependence of the return of atrial mechanical function on the mode of cardioversion of atrial fibrillation to sinus rhythm. Am J Cardiol. 1995;75:624-626.
47. Harjai KJ, Mobarek SK, Cheirif J, Boulos LM, Murgo JP, Abi-Samra F. Clinical variables affecting recovery of left atrial mechanical function after cardioversion from atrial fibrillation. J Am Coll Cardiol. 1997;30: 481-486.
48. Grimm RA, Stewart WJ, Maloney JD, Cohen GI, Pearce GL, Salcedo EE, Klein AL. Impact of electrical cardioversion of atrial fibrillation on left atrial appendage function and spontaneous echo contrast: characterization by simultaneous transesophageal echocardiography. J Am Coll Cardiol. 1993;22:1359-1366.
49. Corrado G, Tadeo G, Manzillo GF, Spata M, Tagllagambe LM, Santarone M. Atrial thrombus resolution due to anticoagulation: a transesophageal echocardiographic study. Bologna, Italy: International Meeting on Atrial Fibrillation; 1997. Abstract.
50. Blackshear JL, Pearce LA, Asinger RW, Dittrich HC, Goldman ME, Zabalgoitia M, Rothbart RM, Halperin JL, Stroke Prevention in Atrial Fibrillation Investigators. Mitral regurgitation associated with reduced thromboembolic events in high-risk patients with nonrheumatic atrial fibrillation. Am J Cardiol. 1993;72:840-843.
51. Ezekowitz MD, James KE, Nazarian SM, Davenport J, Broderick JP, Gupta SR, Thadani V, Meyer ML, Bridgers SL, the Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. Circulation. 1995;92:2178-2182.
52. Collins LJ, Silverman DI, Douglas PS, Manning WJ. Cardioversion of non-rheumatic atrial fibrillation: reduced thromboembolic complications with 4 weeks of precardioversion anticoagulation are related to atrial thrombus resolution. Circulation. 1995;92:160-163.
53. Black IW, Fatkin D, Sagar KB, Khandheria BK, Leung DY, Galloway JM, Feneley MP, Walsh WF, Grimm RA, Stollberger C, Verhost PMJ, Klein AL. Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation: a niulticenter study. Circulation. 1994;89:2509-2513.
54. Shapiro EP, Effron MB, Lima S, Ouyang P, Siu CO, Bush D. Transient atrial dysfunction after conversion of chronic atrial fibrillation to sinus rhythm. Am J Cardiol. 1988;62:1202-1207.
55. Fatkin D, Kuchar DL, Thorburn CW, Feneley MP. Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for 'atrial stunning' as a mechanism of thromboembolic complications. J Am Coll Cardiol. 1994;23:307-316.
56. Dote K, Kuwashima R, Nakano Y, Kimura M, Ueda T, Nakaoka K, Mituda H, Okuhara T. Treatment of left atrial appendage thrombus (LAA) in patients with non-valvular atrial fibrillation (NVAF): surgical removal or warfarin therapy based on transesophageal echocardiographic (TEE) morphology. Circulation. 1997;96(suppl I):I-103. Abstract.
57. Seto TB, Taira DA, Manning WJ. Atrial fibrillation and left atrial thrombi: is follow-up TEE before cardioversion necessary? A cost-effectiveness analysis. Circulation. 1997;96(suppl I):I-25. Abstract.
58. Seto TB, Taira DA, Tsevat J, Manning WJ. Cost-effectiveness of transesophageal echocardiography-guided cardioversion for hospitalized patients with atrial fibrillation. J Am Coll Cardiol. 1997;29:122-130.
59. Klein AL, Grimm RA, Black IW, Orsinelli DA, Manning WJ, Stoddard MF, Peidmonte M. Cost effectiveness of TEE-guided cardioversion with anticoagulation compared to conventional therapy in patients with atrial fibrillation. J Am Coll Cardiol. 1994;23(suppl):128A. Abstract.
60. Stoddard MF, Dawkins PR, Prince CR, Ammash NM. Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study. J Am Coll Cardiol. 1995;25:452-459.
61. Weigner MJ, Caulfield TA, Danias PG, Silverman DI, Manning WJ. Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation of less than 48 hours' duration. Ann Intern Med. 1997;126:615-620.
62. Mitchell MA, Hughes GS, Ellenbogen KA, Leonard LB, Dietrich C, Sargent DA, Tschinkel MB, Wood MA, DiMarco JP. Cardioversion-related stroke rates in atrial fibrillation and atrial flutter. Circulation. 1997;96(suppl I):I-453. Abstract.
63. Santiago D, Warshofsky M, Li Mandri G, Di Tullio M, Commuas J, Reiffel J, Homma S. Left atrial appendage function and thrombus formation in atrial fibrillation-flutter: a transesophageal echocardiographic study. J Am Coll Cardiol. 1994;24:159-164.
64. Chalasani P, Cambre S, Silverman ME. Direct-current cardioversion for the conversion of atrial flutter. Am J Cardiol. 1996;77:658-660.
65. Irani WN, Graybum PA, Afridi I. Prevalence of thrombus, spontaneous echo contrast and atrial stunning in patients undergoing cardioversion of atrial flutter: a prospective study using transesophageal echocardiography. Circulation. 1997;95:962-966.
66. Mehta D, Ip JH, Mann N, Worcheimer D, Eikerentse D, Grimes D, Gomes AJ. Incidence of atrial thrombi in patients with first presentation of atrial flutter undergoing electrical cardioversion: a prospective study. Circulation. 1997;96(suppl I):I-453. Abstract.
67. Grimm RA, Tsui KL, Vaughn SE, Agler DA, Scalia GM, Chung MK, Arheart KL, Murray RD, Klein AL, and ACUTE Investigators. TEE-guided early cardioversion of atrial flutter: results from the ACUTE trial registry. Circulation. 1997;96(suppl I):I-25. Abstract.